These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3835424)

  • 41. Antitrust implications of health planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City.
    Chase JB
    Am J Law Med; 1982; 8(3):321-48. PubMed ID: 7168454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitrust implications of chiropractic Peer Review Committees.
    Volper V
    Am J Law Med; 1982; 8(1):45-68. PubMed ID: 7124747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitrust and professional activities.
    Hirsh BD
    JAMA; 1983 Jul 22-29; 250(4):491-2. PubMed ID: 6864945
    [No Abstract]   [Full Text] [Related]  

  • 44. Provider-sponsored ADSs: reducing antitrust liability after Maricopa.
    Walsh JH; Feller H
    Spec Law Dig Health Care (Mon); 1985 Apr; 7(2):5-25. PubMed ID: 10270877
    [No Abstract]   [Full Text] [Related]  

  • 45. Medical care at predetermined prices does not violate antitrust laws.
    Rothschild IS
    Health Law Vigil; 1987 Apr; 10(9):5-6, 12. PubMed ID: 10281338
    [No Abstract]   [Full Text] [Related]  

  • 46. Perspectives. PPOs face antitrust problems.
    Wash Rep Med Health; 1984 Nov; 38(44):suppl 4p. PubMed ID: 10268861
    [No Abstract]   [Full Text] [Related]  

  • 47. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
    Levitt DM
    Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hospital medical staff privileges and antitrust: an overview.
    Weissburg C; Waxman JM
    Rev Fed Am Hosp; 1981; 14(6):48-51. PubMed ID: 10253024
    [No Abstract]   [Full Text] [Related]  

  • 49. Limiting restrictive covenants.
    Burke MR
    Fam Pract Manag; 2001 Apr; 8(4):50. PubMed ID: 11331983
    [No Abstract]   [Full Text] [Related]  

  • 50. Federal judge says Blue Shield of Virginia justified in limiting reimbursement to psychologists.
    Hosp Community Psychiatry; 1979 Jul; 30(7):493, 497. PubMed ID: 447237
    [No Abstract]   [Full Text] [Related]  

  • 51. Most-favored-nation clauses and monopsonistic power: an unhealthy mix?
    Stenger SE
    Am J Law Med; 1989; 15(1):111-28. PubMed ID: 2764011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny.
    Allen HS; Rothschild IS
    Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389
    [No Abstract]   [Full Text] [Related]  

  • 53. U.S. District Court finds Blue Shield physician payment method violates Sec. 1 of the Sherman Act.
    Laurence K; Kinney ED
    Health Law Vigil; 1984 Mar; 7(7):4-7. PubMed ID: 10278231
    [No Abstract]   [Full Text] [Related]  

  • 54. Competition in health insurance markets.
    Pauly MV
    Law Contemp Probl; 1988; 51(2):237-71. PubMed ID: 10295964
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluating antitrust risk in joint provider negotiations with payors.
    Leonard EJ
    Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Blues interfered illegally with HMO.".
    Burda D
    Mod Healthc; 1987 Nov; 17(24):12. PubMed ID: 10284683
    [No Abstract]   [Full Text] [Related]  

  • 57. Antitrust immunity in Colorado peer review actions.
    Earnest GL
    Hosp Law Newsl; 1989 Dec; 7(2):1-5. PubMed ID: 10296371
    [No Abstract]   [Full Text] [Related]  

  • 58. Antitrust implications of "all-inclusive" payment methodologies: the Empire Blue Cross decision.
    Miles JJ
    Health Law Vigil; 1987 Jun; 10(13):5-7. PubMed ID: 10282184
    [No Abstract]   [Full Text] [Related]  

  • 59. Appeals Court limits antitrust review of physician-hospital disputes.
    Christensen JD
    Health Law Vigil; 1988 Sep; 11(19):3-4. PubMed ID: 10288887
    [No Abstract]   [Full Text] [Related]  

  • 60. Antitrust in the health services industry: the first five years.
    Dolan AK
    Health Med Care Serv Rev; 1981-1982; 3(2-3):13, 15-24. PubMed ID: 10299261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.